Since 1987, our HIV Center Grand Rounds have been engaging scientists, clinicians, community members and leaders in diffusing findings from HIV programming in the US and abroad. In our cutting-edge Grand Rounds, we invite some of the world’s leading experts on HIV prevention, care, and treatment to provide insights into their exciting studies. Podcast recordings of the sessions can be found below.
We encourage you to look through the podcasts and also to subscribe to our HIV Center YouTube Channel.
2018 Grand Rounds
THE CRITICAL ROLE OF BEHAVIORAL RESEARCH IN BIOMEDICAL HIV PREVENTION
Jeffrey T. Parsons, PhD
Hunter College and the Graduate Center of the City University of New York, and the Center for HIV Educational Studies and Training.
Dr. Parsons is a distinguished Professor of Psychology at Hunter College and the Graduate Center and Director of CHEST. His work has shed light on health behaviors, HIV medication adherence, sexual behavior and substance use.
2017 Grand Rounds
INTERVENTIONS TO ADDRESS THE VICIOUS CYCLE OF FOOD INSECURITY AND HIV/AIDS
Sheri Weiser, MD, MPH, MA
School of Medicine and Center for AIDS Prevention Studies, University of California, San Francisco
Dr. Weiser is an internist and Associate Professor of
Medicine at UCSF. Her research focuses on the impact of food insecurity and other structural factors on HIV prevention and treatment outcomes, with a particular focus on food security interventions to improve HIV health outcomes both in the US and in sub-Saharan Africa.
CLOSING THE GAPS IN THE HIV CARE CONTINUUM IN THE US: LOW-HANGING FRUIT OUTSIDE THE BOX AND OTHER MIXED METAPHORS
Thomas Giordano, MD, MPH
Baylor College of Medicine
Dr. Giordano is an Associate Professor of Medicine and Investigator, at the Michael E. DeBakey VA Medical Center, in Houston, TX. He has been involved in HIV clinical care and research since 2000 and Medical Director of the Thomas Street Health Center. He focuses on improving the HIV care continuum, including retention in HIV care.
MEETING THE CHALLENGES IN THE US SOUTH: ENDING HIV IN ALABAMA THROUGH UAB CFAR, COMMUNITY AND CONSUMER COLLABORATION
Michael Mugavero, MD, MHSc is a Professor of Medicine with Tenure at the UAB at Birmingham, Co-director of the UAB CFAR and HIV Care provider at the UAB 1917 Clinic. His research focuses on the influence of socio-behavioral and contextual factors across the HIV care continuum.
DEVELOPING TECHNOLOGY-BASED HIV PREVENTION FOR YOUNG POPULATIONS
Michele Ybarra, MPH, PhD
Center for Innovative Public Health Research (CiPHR)
Michele Ybarra M.P.H., Ph.D. is the President and Research Director of the Center for Innovative Public Health Research (CiPHR),a non-profit research organization in southern California. Her work focuses on how technology is affecting the health and well being of youth, as well as how we can use technology to promote healthy behaviors.
NETWORK INTERVENTIONS FOR HIV ELIMINATION IN THE US
John Schneider, MD, MPH
Departments of Medicine and Public Health Sciences, University of Chicago
Dr. Schneider is an infectious disease specialist and network epidemiologist in the Departments of Medicine and Public Health Sciences at the University of Chicago. He is also Director of the University of Chicago Center for HIV Elimination. His NIH- and CDC-funded research focuses on how social networks can be leveraged to improve the health of populations at risk for HIV and other sexually transmitted infections in resource restricted settings.
BUILDING THE NEXT STAGE OF IMPLEMENTATION SCIENCE TO SUPPORT HIV PREVENTION
C. Hendricks Brown, PhD
Center for Prevention Implementation Methodology for Drug Abuse and HIV, Northwestern University
Dr. C. Hendricks Brown is a Professor of Psychiatry and Behavioral Sciences at the Northwestern University Feinberg School of Medicine. He directs the NIDA-funded Center for Prevention Implementation Methodology (Ce-PIM) for Drug Abuse and HIV. He has received support from the NIDA, NIMH, and CDC to develop statistical methods for the design and analysis of preventive and early intervention field trials.
TOP 10 GAME-CHANGERS IN HIV MEDICINE
Dr. David Wohl is a Professor of Medicine in the Division of Infectious Diseases at University of North Carolina (UNC). He is Site Leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, Director of the North Carolina AETC, and Co-Director of HIV services for the North Carolina State prison system.
Dr. Wohl's research aims to optimize the treatment and prevention of HIV infection, particularly for vulnerable populations, such as the incarcerated.
HEART TO HEART: A CULTURALLY APPROPRIATE EFFICACIOUS INTERVENTION FOR PLWH OF COLOR WHO HAVE DELAYED, DECLINED, OR DISCONTINUED ART
Marya Viorst Gwadz, Ph.D.
Center for Drug Use and HIV Research,
NYU College of Nursing
Dr. Gwadz is a licensed clinical psychologist, and the Director of the Transdisciplinary Research Methods Core in CDUHR. Her research focuses on identifying approaches to increase health equity among African American/Black and Hispanic populations. She has been leading social and behavioral intervention trials for over two decades, with an emphasis on studies to address HIV and drug use-related health disparities in urban populations of color, and among women.
INTERSECTING EPIDEMICS: EVIDENCED-BASED APPROACHES FOR TREATING DEPRESSION AND HIV/AIDS
Dr. Steven Safren, is a Professsor of Psychology at the University of Miami who conducts domestic and international research on behavioral aspects of HIV prevention and treatment.
Dr. Safren has particular expertise on addressing mental health problems such as depression in psychosocial interventions for adherence to antiretroviral therapy.
PRE-EXPOSURE PROPHYLAXIS IN WOMEN: CHALLENGES AND PROSPECTS
Salim Abdool Karim, M.B.Ch.B., Ph.D., D.Sc..
Center for AIDS Programme of Research in South Africa (CAPRISA) and University of Kwazulu Natal, South Africa
Dr. Abdool Karim is a South African clinical infectious diseases epidemiologist who is widely recognised for his ground-breaking scientific contributions in HIV prevention and treatment. He is Director of the Centre for the AIDS Program of Research in South Africa (CAPRISA) and Professor of Clinical Epidemiology at the Mailman School of Public Health at Columbia University.
2016 Grand Rounds
December 1: MOVING BEYOND TRUVADA: THE NEXT GENERATION OF BIOMEDICAL HIV PREVENTION
Raphael Landovitz, MD, MSc
University of California, Los Angeles
November 17: BEYOND RESERVOIRS AND LATENCY: SOCIAL, BEHAVIORAL AND ETHICAL CONSIDERATIONS IN HIV CURE RESEARCH
Judith Auerbach, PhD
University of California, San Francisco
November 10: CONTEXT MATTERS: ADDRESSING COMMUNITY SOCIAL ENVIRONMENTS TO IMPROVE HIV PREVENTION AND CARE IN SUB-SAHARAN AFRICA
Sheri Lippman, PhD
Center for AIDS Prevention Studies, University of California, San Francisco
October 27: THE CONTINUUM OF CARE AMONG MSM IN CHINA: FINAL RESULTS FROM THE CHINA MP3 STUDY
Sten Vermund, MD, PhD
Vanderbilt University Medical Center
October 13: PSYCHOLOGICAL AND STRUCTURAL FACTORS RELATED TO HEALTH PROMOTION AMONG HIV-INFECTED YOUTH
Patrick Wilson, PhD
Columbia University Mailman School of Public Health
June 16: MODELING DYNAMIC POLICY CHANGES IN NEW YORK STATE: THE HIV TESTING LAW AND BLUEPRINT TO END AIDS
Erika Martin, PhD, MPH
Rockefeller Institute of Government and University at Albany, SUNY
May 26: RANDOMIZED TRIAL OF PATIENT NAVIGATION AND CONTINGENCY MANAGEMENT FOR HOSPITALIZED HIV-POSITIVE SUBSTANCE USERS
Lisa Metsch, PhD
Department of Sociomedical Sciences, Columbia University Mailman School of Public Health
May 12: WOMEN, HIV, AND AGING
Gina Wingood, ScD, MPH
Lerner Center for Public Health Promotion, Columbia University Mailman School of Public Health
April 14: NO TIME TO LOSE: EFFECTS OF EARLY TREATMENT ON THE BRAIN AND THE BODY IN CHILDREN AND ADULTS
Jintanat Ananworanich, MD, PhD
US Military HIV Research Program and SEARCH: Thai Red Cross AIDS Research Center
March 31: HIV AND THE BRAIN IN 2016: WHAT WE KNOW AND WHAT WE NEED TO LEARN
Serena S. Spudich, MD
Division of Neurological Infections and Global Neurology, Yale University
Kenneth Mayer, MD
Beth Israel Deaconess Medical Center, Harvard Medical School, The Fenway Institute
February 18: COMPARISON OF ADHERENCE METHODOLOGIES IN AN ART-NAÏVE COHORT: WHICH BEST PREDICTS VIROLOGICAL AND RESISTANCE OUTCOMES?
Susan J. Little, MD
Department of Medicine, University of California, San Diego